Dakota Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$594K Buy
7,592
+8
+0.1% +$545 0.01% 548
2026
Q1
$490K Sell
7,584
-451
-6% -$31.8K 0.01% 550
2025
Q4
$541K Buy
+8,035
New +$540K 0.01% 536
2025
Q2
Sell
-6,206
Closed -$396K 788
2025
Q1
$396K Buy
+6,206
New +$361K 0.01% 563
2023
Q1
Sell
-3,824
Closed -$218K 630
2022
Q4
$218K Buy
+3,824
New +$196K 0.02% 530

Other funds holding HALO

Dakota Wealth Management's HALO Position: Q2 2026 in Review

Dakota Wealth Management increased its Halozyme (HALO) stake by 0.11% in Q2 2026, buying an estimated $545 and bringing the position to 7,592 shares worth $594K. The position accounts for 0.01% of the portfolio, ranked #548.

Dakota Wealth Management first reported a position in HALO in Q4 2022 and has held it in 5 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Dakota Wealth Management held 7,592 shares of Halozyme worth $594K as of Q2 2026.
  • Dakota Wealth Management bought 8 Halozyme shares in Q2 2026, an estimated $545.
  • Halozyme made up 0.01% of Dakota Wealth Management's portfolio in Q2 2026, its #548 holding.
  • Dakota Wealth Management first reported a position in Halozyme in Q4 2022 and has held it in 5 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.